Stable, recombinant ValiScreen® cell line expressing the Opioid NOP (ORL1) receptor, human recombinant in HEK293 host cells.
For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.
Feature | Specification |
---|---|
Application | Drug Discovery & Development |
Special Ordering Information | Requires accepted Terms and Conditions. Additional agreement needed for commercial use. |
Validation | Binding |
Stable, recombinant ValiScreen® cell line expressing the Opioid NOP (ORL1) receptor, human recombinant in HEK293 host cells.
For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.
Revvity’s ValiScreen cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
Clonal selectionRevvity’s ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.
Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.
Application |
Drug Discovery & Development
|
---|---|
Brand |
ValiScreen
|
Host Cell Line |
HEK293
|
Host Species |
Human
|
Receptor |
Opioid
|
Shipping Conditions |
Shipped in Dry Ice
|
Special Ordering Information |
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
|
Target Class |
GPCR
|
Unit Size |
5 million cells
|
Validation |
Binding
|
Are you looking for resources, click on the resource type to explore further.
G protein coupled-receptors (GPCRs) are one of the most intensively studied drug targets, with up to one-third of all marketed...
We are here to answer your questions.